Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

NT PHARMA

0.340
-0.025-6.85%
Volume:635.00K
Turnover:223.83K
Market Cap:229.16M
PE:-1.57
High:0.365
Open:0.365
Low:0.335
Close:0.365
Loading ...
OverviewCompanyNewsFilings

China NT Pharma Exceeds Profit Guarantees with 2023 Net Profit at RMB122.87 Million, Surpassing Projections by 102.39%

Reuters
·
09 May

China NT Pharma Group to Acquire Three Private Companies for 116 Million Yuan

MT Newswires Live
·
30 Apr

China NT Pharma Group Co. Ltd. Issues Clarification on Financial Figures for Acquisition of Target Companies

Reuters
·
29 Apr

Bullish China NT Pharma Group Insider Buying Worth CN¥48.4m Yet To Pay Off

Simply Wall St.
·
01 Mar

BRIEF-China NT Pharma Sees Net Loss Attributable Of RMB35-37 Mln For Ten Months

Reuters
·
08 Jan

China NT Pharma to Shrink 10-Month Loss

MT Newswires Live
·
08 Jan

China NT Pharma Sees Net Loss Attributable RMB35.0 Mln and RMB37.0 Mln for Ten Months Ended 31 Oct

THOMSON REUTERS
·
08 Jan

China NT Pharma - Expected Result Due to Absence of Loss From Manufacturing and Sale of Proprietary Pharma Products Business in 10 Months

THOMSON REUTERS
·
08 Jan

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Mar 31, 2025 Post Market
Financial Report Announcement
Aug 30, 2024 Post Market
Split&Reverse Split
Jul 03, 2024 10 for 1
Financial Report Announcement
Mar 28, 2024
Financial Report Announcement
Aug 31, 2023

Dividend History

Ex-DateDividend
2016-05-310.01
2017-06-080.025
2018-07-100.035

Valuation Analysis

-4.00
Current
-1.11
Sector Average
3.17%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-4.00
Maximum
-0.24
+1 STD
0.00
Minimum
-4.95
-1 STD
-2.23
Average
-1.11

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.